EUVIMEDEUVIMED entdecken
Crossref

GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice

Meltem Donmez Kutlu, Seda Kose, Kubra Akillioglu

Behavioural Brain Research · 2023

DOI: 10.1016/j.bbr.2023.114386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2023. Verfasst von Meltem Donmez Kutlu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Çukurova University Faculty of Medicine. Department of Physiology, Department of Neurophysiology, Adana 01330, Turkey. Electronic address: meltemdonm…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Schizophrenia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Çukurova Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-like peptide 1 (GLP-1) agonists are among the agents that can be used to treat type 2 diabetes mellitus, and they have also been reported to have neuroprotective effects. This study examined the effects of GLP-1 agonist Liraglutide on CREB, BDNF, Trk-B expression and emotional/cognitive behaviors in an experimental schizophrenia-like behavior model induced by MK-801. MK-801 (0.25 mg/kg, 0.1 ml/kg body weight) and/or Liraglutide (300 mcg/kg) were injected intraperitoneally once a day for 7 weeks into 8-10 weeks old male Balb/c mice (n = 78). Mice were randomly divided into 5 groups: Saline+Saline, MK-801 +Saline, Liraglutide+Saline, MK-801 +Liraglutide co-treatment, and Liraglutide+MK-801 co-treatment. A Morris water maze test, an elevated plus maze test, and an open field test were performed after injection. Western blots were performed on mice' hippocampus and PFC for BDNF, Trk-B, CREB, and p-CREB expression. Our study found that MK-801 impaired emotional and cognitive functions in mice. MK-801 administration did not affect Liraglutide's positive effects on spatial learning and memory activity in the Liraglutide+MK-801 group. Liraglutide administration (Liraglutide+MK-801 group) improved the BDNF/Trk-B and p-CREB/CREB ratio in the hippocampus, and the p-CREB/CREB ratio in the PFC to the control group level. The negative effects of MK-801 on cognitive behavior were not reversed by Liraglutide in the MK-801 +Liraglutide group. In conclusion, Liraglutide does not affect NMDA receptor blockade-induced emotional and cognitive behaviors. However, it has a protective effect against cognitive impairment. Furthermore, it is possible that the GLP-1 receptors in the hippocampus and PFC are involved in the modulation of NMDA receptor activity through CREB activation/deactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2SchizophreniaMaleMiceAnimalsLiraglutideDizocilpine MaleateGlucagon-Like Peptide 1Brain-Derived Neurotrophic FactorMice, Inbred BALB CReceptors, N-Methyl-D-AspartatePrefrontal CortexHippocampus

Stichwörter der Autor:innen

BDNFCREBLiraglutideMK-801MiceSchizophrenia-like behaviorsTrk-B

Substanzen

LiraglutideDizocilpine MaleateGlucagon-Like Peptide 1Brain-Derived Neurotrophic FactorReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Çukurova University Faculty of Medicine. Department of Physiology, Department of Neurophysiology, Adana 01330, Turkey. Electronic address: meltemdonmez@gmail.com.
  • Çukurova University Faculty of Medicine. Department of Physiology, Department of Neurophysiology, Adana 01330, Turkey.

Förderung

  • Çukurova Üniversitesi

Zitieren

APA

Kutlu, M. D., Kose, S., & Akillioglu, K. (2023). GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114386

Vancouver

Kutlu MD, Kose S, Akillioglu K. GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice. Behavioural Brain Research. 2023. doi:10.1016/j.bbr.2023.114386

BibTeX
@article{Kutlu2023,
  author = {Kutlu, Meltem Donmez and Kose, Seda and Akillioglu, Kubra},
  title = {GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice},
  journal = {Behavioural Brain Research},
  year = {2023},
  doi = {10.1016/j.bbr.2023.114386}
}
Kostenlos starten →